Mr. Farrugia listed these five things as most worth watching in precision medicine:
- Pharmacogenomics
- Liquid biopsy
- Non-invasive prenatal testing
- Whole genome sequencing
- Microbiome
He noted that President Obama’s Precision Medicine Initiative got enough attention to enroll one million necessary clinical-trial participants. “We don’t need to pitch it very hard. We’ve never had an undersubscription of trials in this space. We don’t need to sell something here.”
He said that patient engagement and data privacy are keys to pushing precision medicine to a more scalable level.
He had a good line about the future of precision medicine.
“I hope I can’t imagine it. If I can imagine it, it won’t be that exciting.”
